In the context of cancer, eltrombopag is particularly valuable for patients undergoing chemotherapy, which often leads to thrombocytopeniaâa condition characterized by abnormally low levels of platelets. This drug helps maintain adequate platelet counts, allowing patients to continue with their chemotherapy regimens without interruptions, which can be critical for effective cancer treatment.
